APA (7th ed.) Citation

Finlin, B. S., Memetimin, H., Zhu, B., Confides, A. L., Vekaria, H. J., El Khouli, R. H., . . . Kern, P. A. (2020). The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans. The Journal of clinical investigation, 130(5), 2319-2331. https://doi.org/10.1172/JCI134892

Chicago Style (17th ed.) Citation

Finlin, Brian S., et al. "The β3-adrenergic Receptor Agonist Mirabegron Improves Glucose Homeostasis in Obese Humans." The Journal of Clinical Investigation 130, no. 5 (2020): 2319-2331. https://doi.org/10.1172/JCI134892.

MLA (9th ed.) Citation

Finlin, Brian S., et al. "The β3-adrenergic Receptor Agonist Mirabegron Improves Glucose Homeostasis in Obese Humans." The Journal of Clinical Investigation, vol. 130, no. 5, 2020, pp. 2319-2331, https://doi.org/10.1172/JCI134892.